Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies

Human islet amyloid polypeptide (hIAPP) is a naturally occurring, intrinsically disordered protein whose abnormal aggregation into amyloid fibrils is a pathological feature in type 2 diabetes, and its cross-aggregation with amyloid beta has been linked to an increased risk of Alzheimer’s disease. Th...

Full description

Bibliographic Details
Main Authors: Moore, S., Sonar, K., Bharadwaj, Prashant, Deplazes, Evelyne, Mancera, Ricardo
Format: Journal Article
Published: M D P I AG 2018
Online Access:http://hdl.handle.net/20.500.11937/71838
_version_ 1848762586108002304
author Moore, S.
Sonar, K.
Bharadwaj, Prashant
Deplazes, Evelyne
Mancera, Ricardo
author_facet Moore, S.
Sonar, K.
Bharadwaj, Prashant
Deplazes, Evelyne
Mancera, Ricardo
author_sort Moore, S.
building Curtin Institutional Repository
collection Online Access
description Human islet amyloid polypeptide (hIAPP) is a naturally occurring, intrinsically disordered protein whose abnormal aggregation into amyloid fibrils is a pathological feature in type 2 diabetes, and its cross-aggregation with amyloid beta has been linked to an increased risk of Alzheimer’s disease. The soluble, oligomeric forms of hIAPP are the most toxic to ß-cells in the pancreas. However, the structure of these oligomeric forms is difficult to characterise because of their intrinsic disorder and their tendency to rapidly aggregate into insoluble fibrils. Experimental studies of hIAPP have generally used non-physiological conditions to prevent aggregation, and they have been unable to describe its soluble monomeric and oligomeric structure at physiological conditions. Molecular dynamics (MD) simulations offer an alternative for the detailed characterisation of the monomeric structure of hIAPP and its aggregation in aqueous solution. This paper reviews the knowledge that has been gained by the use of MD simulations, and its relationship to experimental data for both hIAPP and rat IAPP. In particular, the influence of the choice of force field and water models, the choice of initial structure, and the configurational sampling method used, are discussed in detail. Characterisation of the solution structure of hIAPP and its mechanism of oligomerisation is important to understanding its cellular toxicity and its role in disease states, and may ultimately offer new opportunities for therapeutic interventions.
first_indexed 2025-11-14T10:49:55Z
format Journal Article
id curtin-20.500.11937-71838
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:49:55Z
publishDate 2018
publisher M D P I AG
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-718382019-01-15T03:11:06Z Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies Moore, S. Sonar, K. Bharadwaj, Prashant Deplazes, Evelyne Mancera, Ricardo Human islet amyloid polypeptide (hIAPP) is a naturally occurring, intrinsically disordered protein whose abnormal aggregation into amyloid fibrils is a pathological feature in type 2 diabetes, and its cross-aggregation with amyloid beta has been linked to an increased risk of Alzheimer’s disease. The soluble, oligomeric forms of hIAPP are the most toxic to ß-cells in the pancreas. However, the structure of these oligomeric forms is difficult to characterise because of their intrinsic disorder and their tendency to rapidly aggregate into insoluble fibrils. Experimental studies of hIAPP have generally used non-physiological conditions to prevent aggregation, and they have been unable to describe its soluble monomeric and oligomeric structure at physiological conditions. Molecular dynamics (MD) simulations offer an alternative for the detailed characterisation of the monomeric structure of hIAPP and its aggregation in aqueous solution. This paper reviews the knowledge that has been gained by the use of MD simulations, and its relationship to experimental data for both hIAPP and rat IAPP. In particular, the influence of the choice of force field and water models, the choice of initial structure, and the configurational sampling method used, are discussed in detail. Characterisation of the solution structure of hIAPP and its mechanism of oligomerisation is important to understanding its cellular toxicity and its role in disease states, and may ultimately offer new opportunities for therapeutic interventions. 2018 Journal Article http://hdl.handle.net/20.500.11937/71838 10.3390/molecules23092142 http://creativecommons.org/licenses/by/4.0/ M D P I AG fulltext
spellingShingle Moore, S.
Sonar, K.
Bharadwaj, Prashant
Deplazes, Evelyne
Mancera, Ricardo
Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
title Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
title_full Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
title_fullStr Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
title_full_unstemmed Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
title_short Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
title_sort characterisation of the structure and oligomerisation of islet amyloid polypeptides (iapp): a review of molecular dynamics simulation studies
url http://hdl.handle.net/20.500.11937/71838